[Remote] Director, R&D Software Engineering at Clairo

United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Bachelor’s degree in Computer Science, Software Engineering, or a related technical field (advanced degree preferred)
Minimum of 10 years of technical experience, including software engineering leadership
Proven track record managing multi-disciplinary engineering teams in global environments
Strong background in full-stack development, cross-platform development, cloud architecture (AWS preferred)
Demonstrated success leading platform modernization and automation initiatives
Skilled in agile methodologies and driving continuous improvement across engineering processes
Experience in technology-driven or clinical software environments preferred; exclude backgrounds primarily in banking, finance, or insurance
Excellent communication and stakeholder management skills with the ability to drive organizational change

Responsibilities

Lead the modernization of Clario’s clinical trial software platform, advancing front-end and back-end systems built on .NET, AWS, and Java integrating with medical device endpoints and modern mobile applications
Define and execute R&D’s technical strategy in partnership with executive leadership to enhance speed, reliability, and scalability
Oversee multiple development teams (2 direct reports and ~40–50 indirect, including contractors) focused on platform transformation, automation, and QA maturity
Drive adoption of DevOps, CI/CD, and test automation practices to ensure quality, maintainability, and faster delivery
Collaborate with Product Management, Quality Assurance, and Clinical Systems to align development efforts with customer and business priorities
Foster a high-performing engineering culture that values innovation, accountability, and cross-functional collaboration
Provide strong architectural oversight, ensuring scalable and secure systems that meet Clario’s global operational needs
Mentor and develop technical leaders, ensuring continuous learning, skill development, and organizational alignment
Champion global cultural transformation—bridging experienced team members with new talent and promoting shared ownership of modernization initiatives
Participate in senior management discussions to shape corporate engineering strategy and ensure alignment with Clario’s long-term business goals

Skills

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free